Experience can
raise good questions.

Look for signals. Keep the context.

A detailed account can describe an experience, an unexpected outcome, or a question that a study has not addressed. Several similar reports may suggest a pattern worth investigating. They do not, by themselves, show that a peptide caused the outcome.

Structure makes experiences easier to understand.

• The exact compound or product being discussed.
• The outcome observed, when it occurred, and how it was measured.
• Other treatments, training changes, or circumstances that could affect the result.
• Whether the account is a first-hand observation, and what cannot be verified.
• Any relevant financial or commercial interest.

Transparent summaries, with context.

Published summaries will identify their source as community-reported, show the number of reports behind a statement, describe missing information, and include unfavorable or conflicting observations. Product identity and other details may remain unverified. A published report is not an endorsement.

People who choose to report an experience may differ from those who do not. Expectations, other exposures, incomplete records, and selective reporting can affect what we see. We will keep these limitations next to the findings.

What the community recommends—and why

When documented advice is available, each compound’s community section will distinguish the recommendation, contributors’ reasoning, evidence checks and cautions. We will name the source coverage and date, include disagreement, and avoid calling an opinion a consensus without support. Public discussion sources and reports submitted to this site will be identified separately.

What research gaps can tell us.

When clinical evidence is limited, we will say so. Commercial incentives or research funding may be relevant to an evidence gap, but any explanation for that gap needs its own support. Missing studies do not establish safety, benefit, or the reason the studies are missing.